True Leaf Medicine International Ltd. formed the True Leaf Medical Advisory Board (“MAB”) under its chief scientific officer. This team of three leading B.C. medical practitioners is committed to advancing integrative healthcare with cannabis.
Dr. Chris Spooner, a respected naturopathic doctor and champion of integrative medicine, will lead the MAB in his role as chief scientific officer. Dr. Spooner will be joined by Dr. Caroline MacCallum and Dr. Zeid Mohamedali, two of the most progressive medical doctors advising the cannabis industry today.
The True Leaf MAB will oversee the research and development of a highly-effective medicinal cannabis product line to address neurological, musculoskeletal, gynecological and gastrointestinal conditions.
“Today’s announcement is a significant milestone in our mission to be Canada’s leading purpose-driven cannabis company,” said Darcy Bomford, founder and chief executive officer of True Leaf. “Our MAB has the expertise to help us research and develop world-class medicinal cannabis products that fill the gaps that exist in medical treatment today. These doctors have extensive success treating patients with cannabis who have found their pharmaceutical treatments ineffective or intolerable. They have taken a progressive approach to treating their patients, and because of that, have helped people live happier, healthier lives.”
The True Leaf MAB is a group of accomplished medical cannabis advisors who will also help the company create strategic partnerships within the medical community, provide education and outreach to physicians and policy makers, and identify opportunities for research on medicinal cannabis.
True Leaf has also received permission by Health Canada to build its True Leaf Campus cannabis cultivation facility and broke ground on March 2, 2018. The 25,000 square foot facility is expected to be completed in late summer 2018.